Low Grade Serous Carcinoma clinical trials at UC Health

• Ribociclib and Letrozole Treatment in Ovarian Cancer

  open to eligible females ages 18 years and up

  The study evaluates the response to treatment with Ribociclib and Letrozole in patients with low grade serous cancer of the ovary, fallopian tube or peritoneum.

  at UCSF

Last updated: June 10, 2020